Human Medicines Highlights: August 2026

5th August 2026

Summary: The August 2026 edition of Human Medicines Highlights focuses on recent regulatory decisions and innovation at the European Medicines Agency. Key developments include positive recommendations for new treatments for wet age-related macular degeneration and plaque psoriasis, the launch of a phased review for a promising pancreatic cancer medicine to accelerate assessment, and strengthened collaboration to support health innovation across Europe. The newsletter also highlights recent committee decisions on new and updated medicines, upcoming stakeholder events on AI, women's health and pharmacovigilance, new public consultations, and EMA's continued commitment to transparency, stakeholder engagement and diversity.

Link: https://ec.europa.eu/newsroom/ema/newsletter-archives/78235

Back to Recent News